Table 2.

Predicted drug susceptibility scores of efavirenz, doravirine, rilpivirine and etravirine

Efavirenz	Susceptible	Low-level resistance	Intermediate resistance	High-level resistance
	Etravirine
Susceptible (36)	34 (94.4%)	2 (5.6%)	0 (0%)	0 (0%)
Low level resistance (1)	1 (100%)	0 (0%)	0 (0%)	0 (0%)
Intermediate resistance (2)	1 (50%)	0 (0%)	1 (50%)	0 (0%)
High level resistance (142)	36 (25.2%)	33 (23.2%)	49 (34.5%)	25 (17.6%)
Total (182)	72 (39.2%)	35 (19.3%)	50 (27.6%)	25 (13.8%)
	Rilpivirine
Susceptible (36)	34 (94.4%)	2 (5.6%)	0 (0%)	0 (0%)
Low level resistance (1)	1 (100%)	0 (0%)	0 (0%)	0 (0%)
Intermediate resistance (2)	1 (50%)	0 (0%)	1 (50%)	0 (0%)
High level Resistance (142)	36 (25.2%)	33 (23.2%)	49 (34.5%)	25 (17.6%)
Total (182)	72 (39.2%)	35 (19.3%)	50 (27.6%)	25 (13.8%)
	Doravirine
Susceptible (36)	36 (100%)	0 (0%)	0 (0%)	0 (0%)
Low level resistance (1)	1 (100%)	0 (0%)	0 (0%)	0 (0%)
Intermediate resistance (2)	1 (50%)	0 (0%)	1 (50%)	0 (0%)
High level Resistance (142)	22 (15.4%)	23 (16.1%)	54 (37.8%)	44 (30.8%)
Total (182)	60 (33%)	23 (12.6%)	55 (30.2%)	44 (24.2%)